<DOC>
	<DOCNO>NCT01541891</DOCNO>
	<brief_summary>The purpose study evaluate efficacy safety PRO-148 ophthalmic solution compare SYSTANE ® ophthalmic solution treatment sign symptoms mild-to-moderate dry eye syndrome .</brief_summary>
	<brief_title>Efficacy Safety PRO-148 Ophthalmic Solution Versus SYSTANE® Treatment Patients With Dry Eye Syndrome</brief_title>
	<detailed_description>A phase 2 , randomize , double mask clinical , parallel-group clinical trial evaluate efficacy safety PRO-148 ophthalmic solution compare SYSTANE ® ophthalmic solution treatment sign symptoms mild-to-moderate dry eye syndrome .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Keratoconjunctivitis Sicca</mesh_term>
	<mesh_term>Dry Eye Syndromes</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>Patients diagnosis mildtomoderate drye eye syndrome . Male female patient . Patients 18 year age Patients one blind eye . Visual acuity 20/40 eye Patients history active stage concomitant ocular disease . Patients take medication , topically route , could interfere study 's result , 3 day prior trial time period residual effect could present . Contraindications sensitivity component study treatment . Ocular surgery within past 3 month . Contact lens user . Females childbearing potential ) may participate study follow condition exist : They pregnant , They breastfeed , They positive urine pregnancy test screening , They intend become pregnant study , They agree use adequate birth control method duration study . Participation study investigational drug within 90 day previous inclusion . Discontinuation criterion : Patients could discontinue completion study adverse event , pregnancy , protocol violation , lack efficacy , administrative reason .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>PRO-148</keyword>
	<keyword>Dry eye syndrome</keyword>
</DOC>